Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus

Journal of the American Society of Nephrology

Volumn 10, Issue 8, 1999, Pages 1778-1785

  Miller, Judith A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ANGIOTENSIN; INULIN; LOSARTAN POTASSIUM;

ADULT; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSING OVER; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN DIET; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SODIUM RESTRICTION; STATISTICAL ANALYSIS; URINARY EXCRETION;

EID: 0032856618     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
3. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG: Effect of hyperglycemia on arterial pressure, plasma renin activity, and renal function in early diabetes. Clin Sci 90: 189-195, 1996
4. Woods LL, Mizelle HL, Hall JG: Control of renal hemodynamics in hyperglycemia: Possible role of tubuloglomerular feedback. Am J Physiol 252: F65-F73, 1987
5. O'Hare JA, Ferriss JB, Twomey BM, Gonggrijp H, O'Sullivan DJ: Changes in blood pressure, body fluids, circulation angiotensin II and aldosterone, with improved diabetes control. Clin Sci 63: 415s-418s, 1982
6. White NH, Skor D, Santiago JV: Practical closed-loop insulin delivery: A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med 97: 210-213, 1982
7. Miller JA: Renal responses to sodium restriction in early diabetes. J Am Soc Nephrol 8: 749-755, 1997
8. Dalton RN, Wiseman MJ, Turner C, Viberti GC: Measurement of urinary para-aminohippuric acid in glycosuric diabetics. Kidney Int 34: 117-120, 1988
9. Walser M, Davidson DG, Orloff J: The renal clearance of alkali-stable inulin. J Clin Invest 34: 1520-1523, 1955
10. Brun C: A rapid method for the determination of para-aminohippuric acid in kidney function tests. J Lab Clin Med 37: 955-958, 1951
11. Brands MW, Hopkins TE: Poor glycemic control induces hypertension in diabetes mellitus. Hypertension 27[Part 2]: 735-739, 1996
12. Baron AD: Hemodynamic actions of insulin. Am J Physiol 267: E187-E202, 1994
13. Egan BM, Stepniakowski K: Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives. J Hypertens 12: 1061-1067, 1994
14. Kawai N, Keep RF, Betz AL: Effects of hyperglycemia on cerebral blood flow and edema formation after carotid artery occlusion in Fischer 344 rats. Acta Neurochir Suppl 70: 34-36, 1997
15. Jin JS, Bohlen HG: Non-insulin dependent diabetes and hyperglycemia impair rat intestinal flow-mediated regulation. Am J Physiol 272: H728-H734, 1997
16. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95: 1783-1790, 1997
17. Nahser PJ Jr, Brown RE, Oskarsson H, Winnifold MD, Rossen JD: Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91: 635-640, 1995
18. Yokoyama I, Ohtake T, Monomura S, Yonekura K, Shin W-S, Nishikawa J, Sasaki Y, Omata M: Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes 47: 119-124, 1998
19. Miller JA, Anacta L, Cattran DC: Impact of gender on the renal response to angiotensin II. Kidney Int 55: 278-285, 1999
20. Nützi D, Beretta-Piccoli C, Ferrier CP, Link L, Gerber A, Weidmann P: Studies on acute glucose-induced aldosterone suppression: Role of renin-angiotensin system. Klin Wochenschr 62: 213-217, 1984
21. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992
22. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45: 403-410, 1994
23. Deleted in proof.
24. Ray PE, Aguilera G, Kopp JB, Horikoshi S, Klotman PE: Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells. Kidney Int 40: 764-771, 1991
25. Rosenberg ME, Hostetter TH: The effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney. Kidney Int 43: 601-609, 1993
26. Björck S: The renin angiotensin system in diabetes mellitus: A physiological and therapeutic study. Scand J Urol Nephrol Suppl 126: 1-51, 1990
27. Eadington DW, Swainson CP, Frier BM, Semple PF: Renal responses to angiotensin II infusion in early type I (insulin-dependent) diabetes. Diabet Med 8: 524-531, 1991
28. Denton KM, Fennessy PA, Alcom D, Anderson WP: Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruli. Am J Physiol 262: F367-F372, 1992
29. Schnackenberg CG, Wilkins FC, Granger JP: Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs. Hypertension 26: 1024-1029, 1995
30. Arima S, Ito S, Omata K, Takeuchi K, Abe K: High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int 48: 683-689, 1995
31. Miller JA, Abouchacra S, Zinman B, Skorecki KL, Logan AG: Atrial natriuretic factor counteracts the sodium-retaining actions of insulin in normal men. Am J Physiol 265: R584-R590, 1993
32. Wang T-T, Wu X-H, Zhang S-L, Chan JSD: Effect of glucose on the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int 53: 312-319, 1998
33. Zatz R, Meyer TW, Rennke HG, Brenner BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963-5967, 1985
34. Rosenberg ME, Swanson JE, Thomas BL, Hostetter TH: Glomerular and hormonal responses to dietary protein intake in human renal disease. Am J Physiol 253: F1083-F1090, 1987
35. Burnier M, Nussberger J, Biollaz J, Armagnac C, Brouard R, Weber B, Brunner HR: Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. Hypertension 22: 339-347, 1993
36. Pieper GM: Review of alterations in endothelial nitric oxide production in diabetes: Protective role of arginine on endothelial dysfunction. Hypertension 31: 1047-1060, 1998
37. Rodriguez-Manas L, Agulo J, Peiro C, Llergo JL, Sanchez-Ferrer A, Lopez-Doriga P, Sanchez-Ferrer CF: Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br J Pharmacol 123: 1498-1502, 1998
38. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy M-A, Simonson DC, Creager MA: Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97: 1695-1701, 1998
39. Mullen MJ, Clarkson P, Donald AE, Thomson H, Thorne SA, Powe AJ, Furuno T, Bull T, Deanfield JE: Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: A randomized, double-blind study. J Am Coll Cardiol 31: 1330-1335, 1998